Abstract:PurposeEpithelial-mesenchymal transition (EMT) is characterized by a decreased expression of E-cadherin and an increased expression of vimentin, which is associated with poor prognosis in rectal cancer. This study aimed to explore the feasibility of using multi-parameter diffusion and perfusion magnetic resonance imaging (MRI) to evaluate the expression of E-cadherin and vimentin.MethodsOne hundred and ten patients with rectal cancer, who underwent preoperative multi-parameter diffusion and perfusion MRI and subsequent radical resection of rectal carcinoma, were included in this prospective study. The expression of E-cadherin, vimentin, vascular endothelial growth factor (VEGF), and Ki67 was identified by immunohistochemical test and MRI morphology features; quantitative parameters were analyzed and combined diagnostic models were created by binary logistic regression. The receiver operating characteristics curve with area under the curve (AUC) was used to evaluated diagnostic performance. Interobserver agreement for MRI parameters was evaluated by intraclass correlation coefficient .ResultsIn the low expression E-cadherin group, the VEGF expression was significantly higher than the high expression group (60.5% vs 37.3%, P < 0.05), and the Ki67 expression had no significant difference (P > 0.05). In the high expression vimentin group, the Ki67 expression was significantly higher than the low expression group (77.3% vs 56.1%, P < 0.05), and the VEGF expression was not significantly significant (P > 0.05). MRI morphological features had no significant diagnostic efficacy for E-cadherin and vimentin expression in rectal cancer (P > 0.05). There were positive and negative correlations between apparent diffusion coefficient (ADC) values with E-cadherin and vimentin expression (P < 0.05), the Ktrans and Kep values were negatively and positively correlated with the expression of E-cadherin and vimentin (P < 0.05). The ADC value (b = 3000 s/mm2) had mild significant diagnostic efficiencies for low E-cadherin expression and high vimentin expression (AUC = 0.63 and 0.644, P < 0.05), the Ktrans and Kep values had significant diagnostic efficiencies (AUC = 0.801 and 0.724, P < 0.05; AUC = 0.722 and 0.628, P < 0.05, respectively). The combined model of ADC, Ktrans, and Kep values had good diagnostic efficiencies for low E-cadherin expression and high vimentin expression (AUC = 0.814 and 0.728, P < 0.05).ConclusionThe quantitative parameters of diffusion (with ultra-high b-values) and perfusion MRI can assess the major biomarkers of EMT in rectal cancer, and the combined diagnostic model could further improve the evaluating efficiency for EMT, which possibly can provide valuable information for non-invasive and preoperative assessment of the tumor microenvironment.

Predicting lymphovascular invasion in rectal cancer: evaluating the performance of golden-angle radial sparse parallel MRI for rectal perfusion assessment

Golden-angle radial sparse parallel magnetic resonance imaging of rectal perfusion: utility in the diagnosis of poorly differentiated rectal cancer

Quantitative Perfusion Analysis of the Rectum Using Golden-Angle Radial Sparse Parallel Magnetic Resonance Imaging

Quantitative Perfusion Analysis of the Rectum Using Golden-Angle Radial Sparse Parallel Magnetic Resonance Imaging: Initial Experience and Comparison to Time-Resolved Angiography With Interleaved Stochastic Trajectories.

Value of perfusion parameters from golden-angle radial sparse parallel dynamic contrast-enhanced magnetic resonance imaging in predicting pathological complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Preoperative prediction of extramural venous invasion in rectal cancer by dynamic contrast-enhanced and diffusion weighted MRI: a preliminary study

Prediction of false-negative extramural venous invasion in patients with rectal cancer using multiple mathematical models of diffusion-weighted imaging

Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer

Comparison of Diagnostic Performance between Perfusion-Related Intravoxel Incoherent Motion DWI and Dynamic Contrast-Enhanced MRI in Rectal Cancer

Diffusion kurtosis imaging and MRI-detected extramural venous invasion in rectal cancer: correlation with clinicopathological prognostic factors

Biparametric magnetic resonance imaging-based radiomics features for prediction of lymphovascular invasion in rectal cancer

The value of multi-parameter diffusion and perfusion magnetic resonance imaging for evaluating epithelial-mesenchymal transition in rectal cancer

The application of apparent diffusion coefficients derived from intratumoral and peritumoral zones for assessing pathologic prognostic factors in rectal cancer

Combining diffusion kurtosis imaging and clinical data for predicting the extramural venous invasion of rectal adenocarcinoma

Arterial Spin Labeling MRI for Predicting Microvascular Invasion of T1 Staging Renal Clear Cell Carcinoma Preoperatively

Assessment of histologic prognostic factors of resectable rectal cancer: comparison of diagnostic performance using various apparent diffusion coefficient parameters

Combination of single-source dual-energy computed tomography (CT) parameters and extracellular volume fraction for predicting lymphovascular and perineural invasion in colorectal cancer

Diagnostic accuracy of state-of-the-art rectal MRI sequences for the diagnosis of extramural vascular invasion in locally advanced rectal cancer after preoperative chemoradiotherapy: dos or maybes?

R2* mapping and reduced field‐of‐view diffusion‐weighted imaging for preoperative assessment of nonenlarged lymph node metastasis in rectal cancer

Prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology

The application of the golden-angle radial sparse parallel technique in T restaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy